Company intelligence / Profile preview

Sealantium Medical

Netanya, Central Dist., Israelsealantium-med.com ↗

Ownership: Private
Employees: ~6
Development stage: Phase 2

Overview

Sealantium Medical’s sFilm-FS™ has demonstrated successful preclinical efficacy and usability. Early Phase II clinical results show safety and faster performance in controlling surgical bleeding compared to the market-leading product. The technology is positioned as the first innovative hemostatic/sealing patch in nearly a decade to address the $1B+ surgical sealant market.

Therapeutic areas: OtherHematology
Modalities: DeviceBiologic (Fibrin sealant component)Polymer-based medical device (biodegradable polymeric film)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

sFilm-FS

Phase 2

Indications: Surgical bleeding, Tissue sealing

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Sealantium Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sealantium Medical.

Explore the full profile